B4GALT5 inhibits CD8<sup>+</sup> T-cell response by downregulating MHC-I level through ERAD pathway in PDAC.
第一作者:
Xin,Xing
第一单位:
Shanghai Fengxian District Central Hospital, School of Medicine, Anhui University of Science and Technology, Shanghai, China.;Shanghai University of Medicine and Health Sciences Affiliated Sixth People's Hospital South Campus, Shanghai, China.
作者:
医学主题词
人类(Humans);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);半乳糖转移酶类(Galactosyltransferases);癌, 胰腺管(Carcinoma, Pancreatic Ductal);小鼠(Mice);动物(Animals);胰腺肿瘤(Pancreatic Neoplasms);组织相容性抗原Ⅰ类(Histocompatibility Antigens Class I);女(雌)性(Female);男(雄)性(Male);减量调节(Down-Regulation);预后(Prognosis);细胞系, 肿瘤(Cell Line, Tumor)
DOI
10.1136/jitc-2024-010908
PMID
40316305
发布时间
2025-05-07
- 浏览0
Journal for immunotherapy of cancer
2025年13卷5期
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



